Array BioPharma, Inc. Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) announced that it has elected Liam Ratcliffe, M.D., Ph.D., to its Board of Directors as an independent director. Dr. Ratcliffe has extensive background in drug development and translational medicine, including a 12-year tenure at Pfizer.

MORE ON THIS TOPIC